Cysteine cathepsins in human cancer

Abstract Proteases play causal roles in the malignant progression of human tumors. This review centers on the roles in this process of cysteine cathepsins, i.e., peptidases belonging to the papain family (C1) of the CA clan of cysteine proteases. Cysteine cathepsins, most likely along with matrix metalloproteases (MMPs) and serine proteases, degrade the extracellular matrix, thereby facilitating growth and invasion into surrounding tissue and vasculature. Studies on tumor tissues and cell lines have shown changes in expression, activity and distribution of cysteine cathepsins in numerous human cancers. Molecular, immunologic and pharmacological strategies to modulate expression and activity of cysteine cathepsins have provided evidence for a causal role for these enzymes in tumor progression and invasion. Clinically, the levels, activities and localization of cysteine cathepsins and their endogenous inhibitors have been shown to be of diagnostic and prognostic value. Understanding the roles that cysteine proteases play in cancer could lead to the development of more efficacious therapies.

[1]  A. Poole,et al.  Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas , 1978, Nature.

[2]  J. Kos,et al.  Cysteine proteinases in cancer progression and their clinical relevance for prognosis. , 1998, Biological chemistry.

[3]  Bonnie F. Sloane,et al.  Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer , 2001, The Prostate.

[4]  H. Nielsen,et al.  Cathepsin B/Cystatin C Complex Levels in Sera from Patients with Lung and Colorectal Cancer , 2001, Biological chemistry.

[5]  D. Henson,et al.  Biomarkers for early detection of colon cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  R. Frade,et al.  Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. , 1998, Cancer research.

[7]  M. Duffy,et al.  High Levels of Cathepsin B Predict Poor Outcome in Patients with Breast Cancer , 1998, The International journal of biological markers.

[8]  Kwonseop Kim,et al.  N‐ras protein: Frequent quantitative and qualitative changes occur in human colorectal carcinomas , 1997, International journal of cancer.

[9]  J. Kos,et al.  Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking , 2000, British Journal of Cancer.

[10]  K. Resing,et al.  Functional proteomic analysis of melanoma progression. , 2003, Cancer research.

[11]  K. Inoue,et al.  Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer , 1994, Cancer.

[12]  Bonnie F. Sloane,et al.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. , 1992, The Biochemical journal.

[13]  D. Dinh,et al.  Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis , 2004, Oncogene.

[14]  Bonnie F. Sloane,et al.  Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. , 2005, Neoplasia.

[15]  E. Goodwyn,et al.  Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines. , 2002, Cancer letters.

[16]  S. Matsuo,et al.  Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study. , 2000, Lung cancer.

[17]  T. Krieg,et al.  Invasion of melanoma cells into dermal connective tissue in vitro: Evidence for an important role of cysteine proteases , 2003, International journal of cancer.

[18]  C. Gondi,et al.  Elevated levels of cathepsin B in human glioblastoma cell lines. , 2001, International journal of oncology.

[19]  A. Scorilas,et al.  Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. , 2004, Cancer letters.

[20]  Bonnie F. Sloane,et al.  Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-β , 2002, The Journal of Biological Chemistry.

[21]  J. Kos,et al.  Invasion of ras-Transformed Breast Epithelial Cells Depends on the Proteolytic Activity of Cysteine and Aspartic Proteinases , 2001, Biological chemistry.

[22]  Bonnie F. Sloane,et al.  Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. , 1994, Journal of cell science.

[23]  Z. Tulassay,et al.  The role of cysteine and serine proteases in colorectal carcinoma , 1999, Cancer.

[24]  Z. Gokaslan,et al.  Expression and the role of cathepsin H in human glioma progression and invasion. , 1996, Cancer letters.

[25]  Bonnie F. Sloane,et al.  Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. , 2003, Molecular imaging.

[26]  E. Kominami,et al.  Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro. , 1995, Biochemical and biophysical research communications.

[27]  M. Mareel,et al.  Clinical, cellular, and molecular aspects of cancer invasion. , 2003, Physiological reviews.

[28]  Bonnie F. Sloane,et al.  Human Procathepsin B Interacts with the Annexin II Tetramer on the Surface of Tumor Cells* , 2000, The Journal of Biological Chemistry.

[29]  J. Russo,et al.  Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC). , 1995, Biological chemistry Hoppe-Seyler.

[30]  T. Welte,et al.  Cathepsin K expression in human lung. , 2000, Advances in experimental medicine and biology.

[31]  M. Wojtukiewicz,et al.  Cathepsin A activity in primary and metastatic human melanocytic tumors , 2000, Archives of Dermatological Research.

[32]  E. Petricoin,et al.  Proteomics of human breast ductal carcinoma in situ. , 2002, Cancer research.

[33]  Bonnie F. Sloane,et al.  Molecular Regulation of Human Cathepsin B: Implication in Pathologies , 2003, Biological chemistry.

[34]  R. Ménard,et al.  Up‐regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia , 2004, The Prostate.

[35]  G. Huet,et al.  Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. , 1995, Cancer letters.

[36]  F. Sarkar,et al.  Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence , 1994, International journal of cancer.

[37]  J. Kos,et al.  Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. , 2003, Experimental cell research.

[38]  E. Spiess,et al.  Cathepsin B in tumors, normal tissue and isolated cells from the human lung. , 1994, Anticancer research.

[39]  T. Lah,et al.  Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines. , 2002, Cancer letters.

[40]  Bonnie F. Sloane,et al.  Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. , 1995, Journal of neurosurgery.

[41]  Bonnie F. Sloane,et al.  Expression of cathepsins B and S in the progression of prostate carcinoma , 2001, International journal of cancer.

[42]  R. Colella,et al.  Decreased activity of cathepsins L+B and decreased invasive ability of PC3 prostate cancer cells , 2003, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[43]  Robert S. Warren,et al.  A Functional Proteomics Screen of Proteases In Colorectal Carcinoma , 2000, Molecular medicine.

[44]  J. Kos,et al.  Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue. , 1997, Advances in experimental medicine and biology.

[45]  T. Kuo,et al.  Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas , 1998, International journal of cancer.

[46]  J. Kos,et al.  Lysosomal Enzymes, Cathepsins in Brain Tumour Invasion , 2002, Journal of Neuro-Oncology.

[47]  C. Iacobuzio-Donahue,et al.  Elevations in Cathepsin B Protein Content and Enzyme Activity Occur Independently of Glycosylation during Colorectal Tumor Progression* , 1997, The Journal of Biological Chemistry.

[48]  Bonnie F. Sloane,et al.  Interaction of Human Breast Fibroblasts with Collagen I Increases Secretion of Procathepsin B* , 2002, The Journal of Biological Chemistry.

[49]  R. Thomas,et al.  Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  K. Sugimachi,et al.  Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. , 1994, Cancer research.

[51]  D. Turk,et al.  Lysosomal cysteine proteases: facts and opportunities , 2001, The EMBO journal.

[52]  J. Foekens,et al.  Prognostic significance of cathepsins B and L in primary human breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  J. Kos,et al.  Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis , 2003, Cancer Gene Therapy.

[54]  Bonnie F. Sloane,et al.  Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells. , 2003, Neoplasia.

[55]  T. Kageshita,et al.  Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours , 2005, Archives of Dermatological Research.

[56]  P. Hufnagl,et al.  Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer. , 2003, Anticancer research.

[57]  Bonnie F. Sloane,et al.  Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. , 1994, The American journal of pathology.

[58]  M. Murnane,et al.  Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas , 2000, British Journal of Cancer.

[59]  Bonnie F. Sloane,et al.  Degradation of laminin by human tumor cathepsin B , 1989, Clinical & Experimental Metastasis.

[60]  J. Kos,et al.  Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[61]  S. Loening,et al.  Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. , 1999, European journal of cancer.

[62]  M. Bernardo,et al.  Differential Inhibition of Membrane Type 3 (MT3)-Matrix Metalloproteinase (MMP) and MT1-MMP by Tissue Inhibitor of Metalloproteinase (TIMP)-2 and TIMP-3 Regulates Pro-MMP-2 Activation* , 2004, Journal of Biological Chemistry.

[63]  E. Spiess,et al.  Prognostic value of increased lung tumor tissue cathepsin B. , 1994, Anticancer research.

[64]  J. Procházka,et al.  Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. , 1998, Neoplasma.

[65]  Bonnie F. Sloane,et al.  Immunohistochemical localization of cathepsin B in neoplastic human prostate , 1995, The Prostate.

[66]  Bonnie F. Sloane,et al.  Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. , 1994, The American journal of pathology.

[67]  Bonnie F. Sloane,et al.  Cathepsin B expression and localization in glioma progression and invasion. , 1994, Cancer research.

[68]  Izabela Berdowska,et al.  Cysteine proteases as disease markers. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[69]  J. S. Rao,et al.  Molecular mechanisms of glioma invasiveness: the role of proteases , 2003, Nature Reviews Cancer.

[70]  M. Schober,et al.  Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. , 2001, Cancer research.

[71]  G. Kouraklis,et al.  Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells , 2002, Oncogene.

[72]  J. Procházka,et al.  Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer. , 1997, Neoplasma.

[73]  J. Kos,et al.  Cysteine Proteinases and Their Inhibitors in Extracellular Fluids: Markers for Diagnosis and Prognosis in Cancer , 2000, The International journal of biological markers.

[74]  T. Kageshita,et al.  Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours , 2005, Archives of Dermatological Research.

[75]  Bonnie F. Sloane,et al.  Pericellular cathepsin B and malignant progression , 2003, Cancer and Metastasis Reviews.

[76]  J. Kos,et al.  Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma , 2000, Cancer.

[77]  G. Nicolson,et al.  Expression of cysteine protease inhibitors in human gliomas and meningiomas , 1996, Clinical & Experimental Metastasis.

[78]  Bonnie F. Sloane,et al.  Phorbol ester activation of a proteolytic cascade capable of activating latent TGF-β: A process initiated by the exocytosis of cathepsin B , 2002 .

[79]  Bonnie F. Sloane,et al.  Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells , 2004, Oncogene.

[80]  J. Kos,et al.  Clinical and Experimental Studies of Cysteine Cathepsins and Their Inhibitors in Human Brain Tumors , 2000, The International journal of biological markers.

[81]  A. Blejec,et al.  Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. , 2002, Cancer detection and prevention.

[82]  D. Gleason,et al.  Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma , 2002, Cancer.

[83]  P. Johnston,et al.  The clinical significance of cathepsin S expression in human astrocytomas. , 2003, The American journal of pathology.

[84]  K. Jaskiewicz,et al.  Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma. , 2004, Neoplasma.

[85]  C. Gondi,et al.  Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis , 2004, Oncogene.

[86]  Bonnie F. Sloane,et al.  Analysis of a Truncated Form of Cathepsin H in Human Prostate Tumor Cells* , 2002, The Journal of Biological Chemistry.

[87]  Jane Fridlyand,et al.  Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. , 2003, Cancer research.

[88]  P. Dettmar,et al.  Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[89]  M. Copin,et al.  Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[90]  V. Turk,et al.  Determination of cathepsins B, H, L and kininogen in breast cancer patients. , 1992, Agents and actions. Supplements.

[91]  Bonnie F. Sloane,et al.  Unraveling the role of proteases in cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[92]  J. Sloane,et al.  The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. , 1997, Cancer research.

[93]  Kathleen R. Cho,et al.  Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. , 2003, Cancer research.

[94]  V. Körber,et al.  Increased activity of cathepsin B in fibroblasts isolated from primary melanoma in comparison to fibroblasts from normal skin , 1998, Experimental dermatology.

[95]  M. Yokoyama,et al.  Expression of cathepsin B and cystatin C in human colorectal cancer. , 1999, Human pathology.

[96]  T. Goldmann,et al.  Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics. , 1998, Journal of experimental & clinical cancer research : CR.

[97]  T. Goldmann,et al.  The expression of proteolytic enzymes at the dermal invading front of primary cutaneous melanoma predicts metastasis. , 1999, Pathology, research and practice.

[98]  Bonnie F. Sloane,et al.  Invasiveness of Transformed Human Breast Epithelial Cell Lines Is Related to Cathepsin B and Inhibited by Cysteine Proteinase Inhibitors , 2003, Biological chemistry.

[99]  Bonnie F. Sloane,et al.  The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score. , 1999, Anticancer research.

[100]  G. Rassner,et al.  Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma , 2001, Cancer.

[101]  Bonnie F. Sloane,et al.  Cathepsin B and glioma invasion , 1999, International Journal of Developmental Neuroscience.

[102]  Z. Naito,et al.  Expression of Cathepsin B and Cystatin C in Human Breast Cancer , 2001, Surgery Today.

[103]  T. Goldmann,et al.  Prognostic Classification of Malignant Melanomas by Combining Clinical, Histological, and Immunohistochemical Parameters , 1999, Oncology.

[104]  J. Kos,et al.  Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis , 2001, British Journal of Cancer.

[105]  Ashraf Khan,et al.  Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[106]  J. Kos,et al.  Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[107]  A. Szpaderska,et al.  An intracellular form of cathepsin B contributes to invasiveness in cancer. , 2001, Cancer research.

[108]  E. Spiess,et al.  Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue. , 1995, Biological chemistry Hoppe-Seyler.

[109]  N. Rosenberg,et al.  Cathepsins D, B, and L in malignant human lung tissue. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[110]  J. Kos,et al.  Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients , 1999, British Journal of Cancer.

[111]  P. Brennan,et al.  Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis. , 2000, Human pathology.

[112]  Bonnie F. Sloane,et al.  Cathepsin B and its role(s) in cancer progression. , 2003, Biochemical Society symposium.

[113]  G. Fuller,et al.  Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells , 2001, Oncogene.

[114]  Bonnie F. Sloane,et al.  Plasma membrane association of cathepsin B in human prostate cancer: Biochemical and immunogold electron microscopic analysis , 2001, The Prostate.

[115]  Bonnie F. Sloane,et al.  Codistribution of procathepsin B and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy , 1998, The Anatomical record.